By combining these results with the findings of previous reports, we propose that simultaneous analysis of multiple genes, including nuclear expression of BRG1, may represent useful biomarkers for the risk of HCC recurrence and may be used to identify patients who should be closely monitored after curative HCC ablation. Here, SMARCA4 is linked to hepatocellular carcinoma.